Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC

Clinical trial NCT06031376 · COMPLETED

Trial details

NCT number: NCT06031376
Sponsor: Hunan Cancer Hospital
Status: COMPLETED
Study type: OBSERVATIONAL

Metastatic Colorectal Adenocarcinoma

Start date: 2019-07-01
Primary completion: 2022-10-31
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.